Harrow Announces Third Quarter 2023 Financial Results
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2023.
- Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2023.
- The Company also posted its third quarter Letter to Stockholders and corporate presentation to the “Investors” section of its website, harrow.com .
- View the full release here: https://www.businesswire.com/news/home/20231113816178/en/
Commenting on Harrow’s third quarter results, Mark L. Baum, CEO of Harrow, said, “During the third quarter, we produced record revenues, a 50% increase over prior‑year revenues. - In summary, 2023, to date, has been a transformational year – and we believe that, because of the strategic actions that we have taken in 2023, we are positioned well for another record-breaking year in 2024.”
Third quarter 2023 figures of merit: